BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6993145)

  • 1. Control of insulin-dependent diabetes with portable miniaturized infusion systems.
    Hepp KD; Renner R; Piwernetz K; Mehnert H
    Diabetes Care; 1980; 3(2):309-13. PubMed ID: 6993145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for the programming of an open-loop insulin infusion device from the biostator glucose controller.
    Service FJ; Rizza RA; Westland RE; Hall LD; Nelson RL; Haymond MW; Clemens AH; Gerich JE
    Diabetes Care; 1980; 3(2):278-84. PubMed ID: 6993141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of juvenile-onset diabetes by subcutaneous infusion of insulin with a portable pump.
    Sherwin RS; Tamborlane WV; Genel M; Felig P
    Diabetes Care; 1980; 3(2):301-8. PubMed ID: 6993144
    [No Abstract]   [Full Text] [Related]  

  • 4. Programmable open-loop micropump insulin delivery system.
    Clemens AH
    Diabetes Care; 1980; 3(2):359-61. PubMed ID: 6993153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy.
    Rizza RA; Gerich JE; Haymond MW; Westland RE; Hall LD; Clemens AH; Service FJ
    N Engl J Med; 1980 Dec; 303(23):1313-8. PubMed ID: 7001229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous intravenous insulin therapy with a miniaturized open-loop system.
    Renner R; Hepp KD; Mehnert H; Franetzki M
    Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of diabetes mellitus by devices.
    Soeldner JS
    Am J Med; 1981 Jan; 70(1):183-94. PubMed ID: 7006391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some engineering aspects of insulin delivery systems.
    Spencer WJ; Bair RE; Carlson GA; Love JT; Urenda RS; Eaton RP; Schade DS
    Diabetes Care; 1980; 3(2):345-50. PubMed ID: 6993151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged peritoneal insulin infusion in a diabetic man.
    Schade DS; Eaton RP; Friedman NM; Spencer W
    Diabetes Care; 1980; 3(2):314-7. PubMed ID: 6993146
    [No Abstract]   [Full Text] [Related]  

  • 10. Electronic flow rate controller for a portable insulin infusion pump.
    Ferguson RT; Zinman B; Marliss EB; Albisser AM
    Diabetes Care; 1980; 3(2):332-7. PubMed ID: 6993149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of program-controlled portable insulin delivery devices.
    Prestele K; Franetzki M; Kresse H
    Diabetes Care; 1980; 3(2):362-8. PubMed ID: 6993154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus.
    Pickup JC; Keen H; Viberti GC; White MC; Kohner EM; Parsons JA; Alberti KG
    Diabetes Care; 1980; 3(2):290-300. PubMed ID: 6993143
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion.
    Reeves ML; Seigler DE; Ryan EA; Skyler JS
    Am J Med; 1982 Apr; 72(4):673-80. PubMed ID: 7041646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy.
    Renard E
    Curr Opin Pharmacol; 2002 Dec; 2(6):708-16. PubMed ID: 12482735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between multi-injection and continuous subcutaneous insulin therapy in insulin-dependent diabetic inpatients.
    Saibene V; Melandri M; Brembilla L; Spotti D; Pozza G
    Acta Diabetol Lat; 1981; 18(1):45-50. PubMed ID: 7010856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term, ambulatory, subcutaneous insulin infusion versus multiple daily injections in brittle diabetic patients.
    Barbosa J; Menth L; Eaton J; Sutherland D; Freier EF; Najarian J
    Diabetes Care; 1981; 4(2):269-74. PubMed ID: 7011745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved control in diabetes with continuous subcutaneous insulin infusion.
    Schiffrin A; Colle E; Belmonte M
    Diabetes Care; 1980; 3(6):643-9. PubMed ID: 7004811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A totally implantable drug infusion defice: laboratory and clinical experience using a model with single flow rate and new design for modulated insulin infusion.
    Buchwald H; Rohde TD; Dorman FD; Skakoon JG; Wigness BD; Prosl FR; Tucker EM; Rublein TG; Blackshear PJ; Varco RL
    Diabetes Care; 1980; 3(2):351-8. PubMed ID: 6993152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose control in mobile type 1 (insulin-dependent) diabetic patients by means of a semi-automatic feedback controlled insulin infusion system.
    Piwernetz K; Renner R; Hepp KD
    Diabetologia; 1982 Sep; 23(3):229-34. PubMed ID: 7128971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A portable infusion pump, programmable with 16 rates.
    Bojsen J; Kølendorf K; Haslev F; Jørgensen K
    Biotelem Patient Monit; 1978; 5(3):123-33. PubMed ID: 754819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.